Bluejay Diagnostics

Bluejay Diagnostics

Health Care Equipment & Supplies
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay’s first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from ‘sample-to-result’ to help medical professionals make earlier and better triage/treatment decisions.

$3.7M

Market Cap • 10/9/2026

2015

(11 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,4

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

2,1

EPS

—

Market Cap

Market Cap

3,7M

EV

-5,8M

EV/Revenue

0

EV/EBITDA

0,8

EV/EBIT

0,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-45,8M

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

186%

Capex/OCF

-5,7%

SBC/OCF

—

% PPE

14,8%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Op. Income 5Y

35,2%

CAGR Net Income 5Y

37%

CAGR OCF 5Y

43,4%

Leverage

N.D./EBITDA

1,3

Debt/Equity

0%

Current Ratio

4,6

Quick Ratio

4,5

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium